Larry Goldstein to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Larry Goldstein has written about Randomized Controlled Trials as Topic.
Connection Strength
1.218
-
Letter by goldstein regarding article, "statins and intracerebral hemorrhage". Circulation. 2012 Jun 12; 125(23):e1015.
Score: 0.319
-
Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke. 1997 Feb; 28(2):307-10.
Score: 0.110
-
Poststroke pharmacotherapy: another ictus. Stroke. 2012 Dec; 43(12):3433-5.
Score: 0.082
-
Left atrial enlargement: a cause of stroke? CMAJ. 2011 Jul 12; 183(10):1129-30.
Score: 0.074
-
Amphetamine trials and tribulations. Stroke. 2009 Mar; 40(3 Suppl):S133-5.
Score: 0.062
-
Carotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke. 2004 Oct; 35(10):2425-7.
Score: 0.046
-
Aspirin: it's hard to beat. Neurology. 2004 Apr 13; 62(7):1036-7.
Score: 0.045
-
Neuroprotective therapy for acute ischaemic stroke: down, but not out. Lancet. 2004 Feb 07; 363(9407):414-5.
Score: 0.045
-
Extracranial carotid artery stenosis. Stroke. 2003 Nov; 34(11):2767-73.
Score: 0.044
-
Neuropharmacology of TBI-induced plasticity. Brain Inj. 2003 Aug; 17(8):685-94.
Score: 0.043
-
Prevention and health services delivery. Stroke. 2003 Feb; 34(2):367-9.
Score: 0.042
-
Amphetamines and related drugs in motor recovery after stroke. Phys Med Rehabil Clin N Am. 2003 Feb; 14(1 Suppl):S125-34, x.
Score: 0.042
-
Stroke in patients with asymptomatic internal-carotid-artery stenosis. N Engl J Med. 2000 Nov 09; 343(19):1420; discussion 1421.
Score: 0.036
-
Effects of amphetamines and small related molecules on recovery after stroke in animals and man. Neuropharmacology. 2000 Mar 03; 39(5):852-9.
Score: 0.034
-
Carotid endarterectomy for stroke prevention in older people. Clin Geriatr Med. 1999 Nov; 15(4):685-700.
Score: 0.033
-
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2019 02; 39(2):e38-e81.
Score: 0.032
-
US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Carotid endarterectomy. Stroke. 1996 May; 27(5):801-6.
Score: 0.026
-
Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke. 2014 May; 45(5):1429-36.
Score: 0.023
-
Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke. 2011 Sep; 42(9):2645-50.
Score: 0.019
-
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008 Dec; 39(12):3297-302.
Score: 0.015
-
Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke. 2006 Jun; 37(6):1427-31.
Score: 0.013
-
Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005 Apr; 36(4):916-23.
Score: 0.012
-
Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology. 2004 Mar 23; 62(6):968-70.
Score: 0.011
-
Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis. 2003; 16(4):389-95.
Score: 0.010